ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain.
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effectiveness of ULTRACET® (a combination
analgesic) as add-on therapy in rheumatoid arthritis patients taking an NSAID (e.g. Advil®,
Motrin® or other nonsteroidal anti-inflammatory drug) or a COX-2 inhibitor (e.g.
Celebrex®).